Presented at the 2022 Annual General Meeting, Anteris Technologies CEO and director, Wayne Paterson, connects live to the Cath Lab in Tbilisi, Georgia for an update on the DurAVR® THV First-in-Human study with implanting physicians, Dr. Christopher Meduri and Dr. Vinayak Bapat. The physicians speak about the successful cases performed and the performance of the ComASUR® Delivery System. Recorded footage provides an inside look as healthcare professionals set up the Cath Lab operating room while setting up and performing the DurAVR® TAVR procedure.